Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - February 2013

Parallel Trade

06 Feb 2013 - 07 Feb 2013 - London, UK

Bookmark and Share

SMi are proud to present their 7th annual Parallel Trade conference. 

Our 2013 agenda will showcase the latest developments in pharmaceutical Parallel Trade, looking at the industry’s rapid expansion and latest arguments from key opinion leaders on this controversial industry. Hear from experts in leading industry sectors; see how big Pharma companies are beginning to combat traders and attempt to prevent counterfeit medicines entering the market. Through case studies see how trading can affect future R&D pipelines in big pharma drug development. Parallel trade has unique, important legal issues attached to it – hear from specialist pharmaceutical lawyers explaining issues with intellectual property and specific aspects of repackaging. 

Reasons why you should attend:

Hear from the industry leaders on both the advantages and disadvantages to patients, drug producers and traders. How does trading affect your business – New market access or potential hazard? 

See how parallel trade is being maintained from both sides of the fence, supply chain protection and specific aspects of repackaging.

Learn how the financial euro crisis has allowed an increase in need for more affordable drugs to supply harder hit countries but also put an increased pressure on pharmaceutical companies who pay for drug development.

Visit our website here:

Alternatively Contact Fateja Begum on telephone +44 (0) 20 7827 6184 or email on

Quote “Technology Network” and save £100

Further information
Scientific News
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
Antibody Treatment Efficacious in Psoriasis
An experimental, biologic treatment, brodalumab, achieved 100 percent reduction in psoriasis symptoms in twice as many patients as a second, commonly used treatment, according to the results of a multicenter clinical trial led by Mount Sinai researchers.
Scientists Test New Gene Therapy for Vision Loss from a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
HIV Patients Should Be Included in Early Clinical Trials of Anti-TB Drugs
Tuberculosis is the number one cause of death in HIV-infected patients in Africa and a leading cause of death in this population worldwide.
Multi-Gene Test Enables Some Breast Cancer Patients to Safely Avoid Chemotherapy
A major study is providing the best evidence to date that a 21-gene test done on the tumor can identify breast cancer patients who can safely avoid chemotherapy.
Low Dose Beta-Blockers As Effective As High Dose After a Heart Attack?
Heart attack patients live as long – or even longer – on one-quarter the suggested dose.
Antidepressants Plus Blood-Thinners Slow Down Brain Cancer
EPFL scientists have found that combining antidepressants with anticoagulants slows down brain tumors (gliomas) in mice.
Old Drug Performs New Tricks
Cambridge-led research reveals the powers of a "wonder drug" that has lain under the noses of doctors for 50 years.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos